Betamethasone + Neomycin Sulphate is a combination topical medication used to treat inflammatory skin conditions complicated by bacterial infections. Betamethasone is a corticosteroid that reduces inflammation, while Neomycin is an antibiotic that helps combat bacterial infections.
This combination is used for:
| Brand Name | Betnozen-N |
|---|---|
| Type | Cream |
| Weight | 0.1%+0.5% |
| Generic | Betamethasone + Neomycin Sulphate (Topical) |
| Manufacturer | Zenith Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Betamethasone works by suppressing the immune response and reducing inflammation through inhibition of inflammatory mediators. Neomycin acts by inhibiting bacterial protein synthesis, thereby stopping bacterial growth and helping clear infections.
Patients may start to see improvement in symptoms such as itching and redness within a few days of starting the treatment. Full therapeutic effects may take several weeks to achieve, depending on the severity of the condition and adherence to the prescribed regimen.
When applied topically, Betamethasone + Neomycin Sulphate is absorbed through the skin. The degree of absorption can vary based on the area of application and the condition of the skin. Betamethasone absorption may be higher in areas with damaged skin.
Topically applied Betamethasone is metabolized in the liver and excreted in the urine. Neomycin, when used topically, has minimal systemic absorption and is primarily excreted in the feces. Systemic absorption of Neomycin is generally low with topical use.
The typical dosage is:
Apply Betamethasone + Neomycin Sulphate topically to clean, dry skin. Gently rub the medication into the affected area until it is evenly distributed. Avoid applying to large areas of the body and avoid using occlusive dressings unless directed by a healthcare provider.
Common side effects may include:
Severe side effects may include:
Topical toxicity is rare but may occur with excessive use or application over large areas. Symptoms of toxicity include significant local irritation or systemic effects such as adrenal suppression. In case of overdose, discontinue use and seek medical advice.
Precautions include:
Interactions are minimal with topical use, but care should be taken when using other topical medications to avoid potential additive effects or adverse reactions. Combining with other corticosteroids or antibiotics should be done with caution and under medical supervision.
Use with caution in patients with:
Drug interactions are rare with topical use, but potential interactions with other topically applied drugs or systemic medications should be monitored, especially if used extensively or for prolonged periods.
No significant food interactions are known. However, maintaining a balanced diet may support overall skin health and improve the efficacy of treatment.
Use during pregnancy should be limited to the lowest effective dose and for the shortest duration possible. The potential risks versus benefits should be assessed, as corticosteroids can cross the placenta and may affect fetal development.
Betamethasone + Neomycin Sulphate should be used with caution during lactation. Avoid applying to the breast area to prevent ingestion by the infant. The benefits and risks should be evaluated by a healthcare provider.
Acute overdose is unlikely with topical application. In cases of excessive application or ingestion, symptoms may include severe local irritation or systemic effects. Discontinue use and consult a healthcare provider for management.
Contraindications include:
Follow the prescribed dosage and application instructions. Do not use more frequently or for a longer duration than recommended. Avoid contact with eyes and mucous membranes. If symptoms persist or worsen, seek medical advice.
Store at room temperature, away from moisture and heat. Keep the medication in its original container, tightly closed, and out of reach of children.
The volume of distribution for Betamethasone and Neomycin in topical application is not well-defined due to minimal systemic absorption. Local distribution at the site of application is significant.
The half-life of Betamethasone is approximately 36 to 54 hours when administered systemically. For topical application, systemic half-life is not a primary consideration. Neomycin has minimal systemic absorption with topical use, so systemic half-life is not typically relevant.
Betamethasone is primarily cleared through hepatic metabolism and renal excretion. Neomycin, when used topically, has minimal systemic clearance, as systemic absorption is low.
See in details version Betnozen-N Cream 0.1%+0.5% also Betnozen-N Cream 0.1%+0.5% in bangla